• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺:髓样癌。

Thyroid: Medullary Carcinoma.

作者信息

Somnay Yash R, Schneider David, Mazeh Haggi

机构信息

Section of Endocrine Surgery, Department of Surgery, University of Wisconsin, K3/704 Clinical Science Center, 600 Highland Avenue, Madison, WI 53792, USA (YS, DS, HM).

出版信息

Atlas Genet Cytogenet Oncol Haematol. 2013 Apr;17(4):291-296. doi: 10.4267/2042/48876.

DOI:10.4267/2042/48876
PMID:28111594
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5242095/
Abstract

Medullary thyroid cancers (MTC) are rare neuroendocrine tumors arising from the parafollicular C-cells of the thyroid. In this review, we provide a general overview of the classification, pathology, and clinical management of MTC. In the latter half, we survey the underlying genetic framework of MTC and its potential implications within a diagnostic and therapeutic context.

摘要

甲状腺髓样癌(MTC)是一种罕见的神经内分泌肿瘤,起源于甲状腺的滤泡旁C细胞。在本综述中,我们概述了MTC的分类、病理学及临床管理。在后半部分,我们探究了MTC的潜在遗传框架及其在诊断和治疗背景下的潜在意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b780/5242095/dfb561bf9f5b/nihms826917f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b780/5242095/dfb561bf9f5b/nihms826917f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b780/5242095/dfb561bf9f5b/nihms826917f1.jpg

相似文献

1
Thyroid: Medullary Carcinoma.甲状腺:髓样癌。
Atlas Genet Cytogenet Oncol Haematol. 2013 Apr;17(4):291-296. doi: 10.4267/2042/48876.
2
Medullary Thyroid Carcinoma: Recent Advances Including MicroRNA Expression.甲状腺髓样癌:包括微小RNA表达在内的最新进展
Endocr Pathol. 2016 Dec;27(4):312-324. doi: 10.1007/s12022-016-9449-0.
3
RAS proto-oncogene in medullary thyroid carcinoma.甲状腺髓样癌中的RAS原癌基因。
Endocr Relat Cancer. 2015 Oct;22(5):R235-52. doi: 10.1530/ERC-15-0070.
4
[Medullary thyroid carcinoma].甲状腺髓样癌
Internist (Berl). 2015 Sep;56(9):1019-31. doi: 10.1007/s00108-014-3638-z.
5
Diversity of mutations in the RET proto-oncogene and its oncogenic mechanism in medullary thyroid cancer.RET 原癌基因突变的多样性及其在甲状腺髓样癌中的致癌机制。
Crit Rev Clin Lab Sci. 2016 Aug;53(4):217-27. doi: 10.3109/10408363.2015.1129529. Epub 2016 Jan 27.
6
Case report of a neuroendocrine tumor of the thyroid gland with limited calcitonin expression: a diagnostic challenge.甲状腺神经内分泌肿瘤伴降钙素表达受限的病例报告:一项诊断挑战。
AME Case Rep. 2019 May 14;3:12. doi: 10.21037/acr.2019.05.01. eCollection 2019.
7
Molecular signatures of medullary thyroid carcinoma by matrix-assisted laser desorption/ionisation mass spectrometry imaging.基质辅助激光解吸电离质谱成像技术对甲状腺髓样癌的分子特征分析。
J Proteomics. 2019 Jan 16;191:114-123. doi: 10.1016/j.jprot.2018.03.021. Epub 2018 Mar 24.
8
Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets.甲状腺髓样癌的分子遗传学:寻找新的治疗靶点
J Mol Endocrinol. 2009 Oct;43(4):143-55. doi: 10.1677/JME-09-0024. Epub 2009 Apr 21.
9
Diagnosis, treatment, and follow-up of medullary thyroid carcinoma: recommendations by the Thyroid Department of the Brazilian Society of Endocrinology and Metabolism.甲状腺髓样癌的诊断、治疗及随访:巴西内分泌与代谢学会甲状腺科的建议
Arq Bras Endocrinol Metabol. 2014 Oct;58(7):667-700. doi: 10.1590/0004-2730000003427.
10
Cofilin is a mediator of RET-promoted medullary thyroid carcinoma cell migration, invasion and proliferation.Cofilin 是 RET 促进的甲状腺髓样癌细胞迁移、侵袭和增殖的介质。
Mol Cell Endocrinol. 2019 Sep 15;495:110519. doi: 10.1016/j.mce.2019.110519. Epub 2019 Jul 25.

引用本文的文献

1
Uncommon metastatic journey: unusual breast metastases of medullary thyroid carcinoma: a case report.罕见的转移历程:甲状腺髓样癌的不寻常乳腺转移:一例报告
BMC Womens Health. 2025 Jan 20;25(1):29. doi: 10.1186/s12905-025-03564-y.
2
Primary small cell thyroid carcinoma combined with poorly differentiated thyroid carcinoma, evidence for a common origin: A case report.原发性小细胞甲状腺癌合并低分化甲状腺癌:共同起源的证据——病例报告
Oncol Lett. 2023 Apr 18;25(6):233. doi: 10.3892/ol.2023.13819. eCollection 2023 Jun.
3
Performance of Contrast-Enhanced Ultrasound in Thyroid Nodules: Review of Current State and Future Perspectives.

本文引用的文献

1
Genetic alterations in medullary thyroid cancer: diagnostic and prognostic markers.甲状腺髓样癌的基因改变:诊断和预后标志物。
Curr Genomics. 2011 Dec;12(8):618-25. doi: 10.2174/138920211798120835.
2
COX-2 expression and tumor angiogenesis in thyroid carcinoma patients among northeast Chinese population-result of a single-center study.中国东北人群甲状腺癌患者中 COX-2 的表达与肿瘤血管生成——一项单中心研究的结果。
Int J Med Sci. 2012;9(3):237-42. doi: 10.7150/ijms.4173. Epub 2012 Apr 19.
3
Recent advances in the molecular pathogenesis and targeted therapies of medullary thyroid carcinoma.
超声造影在甲状腺结节中的应用:现状与未来展望
Cancers (Basel). 2021 Oct 30;13(21):5469. doi: 10.3390/cancers13215469.
4
Crude annual incidence rate of medullary thyroid cancer and RET mutation frequency.甲状腺髓样癌的粗年发病率和 RET 突变频率。
Croat Med J. 2021 Apr 30;62(2):110-119. doi: 10.3325/cmj.2021.62.110.
5
Medullary thyroid carcinoma with breast metastasis: Two case reports.甲状腺髓样癌伴乳腺转移:两例报告
Medicine (Baltimore). 2018 Nov;97(47):e13193. doi: 10.1097/MD.0000000000013193.
6
Data mining of micrornas in breast carcinogenesis which may be a potential target for cancer prevention.乳腺癌发生过程中微小RNA的数据挖掘,其可能成为癌症预防的潜在靶点。
Food Sci Biotechnol. 2016 Mar 31;25(Suppl 1):143-151. doi: 10.1007/s10068-016-0111-x. eCollection 2016.
7
Pycnodysostosis with novel gene mutation and sporadic medullary thyroid carcinoma: A case report.伴有新型基因突变的致密性骨发育不全与散发性甲状腺髓样癌:一例报告
Medicine (Baltimore). 2017 Dec;96(50):e8730. doi: 10.1097/MD.0000000000008730.
8
Recurrent Fusion Genes in Leukemia: An Attractive Target for Diagnosis and Treatment.白血病中的复发融合基因:诊断与治疗的诱人靶点
Curr Genomics. 2017 Oct;18(5):378-384. doi: 10.2174/1389202918666170329110349.
近年来,甲状腺髓样癌的分子发病机制和靶向治疗取得了进展。
Curr Opin Oncol. 2012 May;24(3):229-34. doi: 10.1097/CCO.0b013e328351c71a.
4
Mutational screening of RET, HRAS, KRAS, NRAS, BRAF, AKT1, and CTNNB1 in medullary thyroid carcinoma.对甲状腺髓样癌中的 RET、HRAS、KRAS、NRAS、BRAF、AKT1 和 CTNNB1 进行突变筛查。
Anticancer Res. 2011 Dec;31(12):4179-83.
5
Evidence that polymorphisms in detoxification genes modulate the susceptibility for sporadic medullary thyroid carcinoma.证据表明,解毒基因的多态性调节散发型甲状腺髓样癌的易感性。
Eur J Endocrinol. 2012 Feb;166(2):241-5. doi: 10.1530/EJE-11-0843. Epub 2011 Nov 2.
6
Mammalian target of rapamycin pathway activation is associated to RET mutation status in medullary thyroid carcinoma.哺乳动物雷帕霉素靶蛋白通路的激活与甲状腺髓样癌中的 RET 突变状态相关。
J Clin Endocrinol Metab. 2011 Jul;96(7):2146-53. doi: 10.1210/jc.2010-2655. Epub 2011 May 4.
7
Familial thyroid cancer: a review.家族性甲状腺癌:综述。
Mod Pathol. 2011 Apr;24 Suppl 2:S19-33. doi: 10.1038/modpathol.2010.147.
8
Role of pituitary tumour transforming gene 1 in medullary thyroid carcinoma.垂体瘤转化基因 1 在甲状腺髓样癌中的作用。
Anal Cell Pathol (Amst). 2010;33(5):207-16. doi: 10.3233/ACP-CLO-2010-0536.
9
Diagnostic value of estrogen receptors in thyroid lesions.甲状腺病变中雌激素受体的诊断价值。
Med Sci Monit. 2010 Jul;16(7):BR203-7.
10
Molecular genetics and phenomics of RET mutations: Impact on prognosis of MTC.RET 基因突变的分子遗传学和表型组学:对 MTC 预后的影响。
Mol Cell Endocrinol. 2010 Jun 30;322(1-2):2-7. doi: 10.1016/j.mce.2010.01.012. Epub 2010 Jan 18.